Comment on: Longitudinal risk of serious infections in patients with inflammatory arthritis on immunomodulating therapy compared to controls: Reply.

Saved in:
Bibliographic Details
Title: Comment on: Longitudinal risk of serious infections in patients with inflammatory arthritis on immunomodulating therapy compared to controls: Reply.
Authors: Christensen IE; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Lillegraven S; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Uhlig T; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Provan SA; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Public Health Section, Inland Norway University of Applied Sciences, Elverum, Norway.
Source: Rheumatology advances in practice [Rheumatol Adv Pract] 2025 Jun 05; Vol. 9 (3), pp. rkaf069. Date of Electronic Publication: 2025 Jun 05 (Print Publication: 2025).
Publication Type: Letter
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101736676 Publication Model: eCollection Cited Medium: Internet ISSN: 2514-1775 (Electronic) Linking ISSN: 25141775 NLM ISO Abbreviation: Rheumatol Adv Pract Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2514-1775
DOI:10.1093/rap/rkaf069